VVT MedVVTMF 4 14-Day RSI is 88.56 as of Jul. 13, 2026. GuruFocus rates VVTMF with a GF Score™ of 4/100. The stock has 4 warning signs investors should review. Among 868 Medical Devices & Instruments companies, VVT Med ranks worse than 93.43% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-13), VVT Med's 14-Day RSI is 88.56.
The industry rank for VVT Med's 14-Day RSI or its related term are showing as below:
VVTMF's 14-Day RSI is ranked worse than 93.43% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 47.695
vs VVTMF: 88.56
VVT Med (OTCPK:VVTMF) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
VVT Med 14-Day RSI Related Terms
VVTMF vs ABT, SYK, MDT: 14-Day RSI Comparison
For the Medical Devices subindustry, VVT Med's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VVT Med 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, VVT Med's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where VVT Med's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VVT Med (VVTMF) has a 14-Day RSI of 88.56 as of Jul. 13, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on VVT Med and its competitors. According to the industry distribution chart, VVT Med ranks #811 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 93.4%.
Is VVT Med's 14-Day RSI too high?
VVT Med's current 14-Day RSI is 88.56. The Medical Devices & Instruments industry median 14-Day RSI is 47.70. VVT Med's value of 88.56 is 85.7% above this industry median. Based on the distribution chart, VVT Med ranks #811 out of 868 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, VVT Med has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does VVT Med's 14-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, VVT Med ranks #811 out of 868 companies for 14-Day RSI. This places VVT Med in the lower half of its industry. The industry median 14-Day RSI is 47.70. VVT Med's value of 88.56 is 85.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 47.70, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. VVT Med's current 14-Day RSI of 88.56 is 85.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on VVT Med and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 47.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. VVT Med's current 14-Day RSI is 88.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VVT Med stock overvalued right now?
VVT Med (VVTMF) has a current 14-Day RSI of 88.56. The current 14-Day RSI is 88.56 and 85.7% above the Medical Devices & Instruments industry median of 47.70. VVT Med's overall GF Score™ is 4/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For VVT Med (VVTMF), the current 14-Day RSI is 88.56 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
VVT Med Inc is a medical device company, focused on developing and commercializing a range of minimally invasive technologies for treating varicose veins. VVT's research and development activities are based in Israel. The company proudly boasts three products within its portfolio that have achieved commercial production status and are currently available in the market. These products have undergone meticulous design processes, obtaining regulatory approvals across multiple countries.
4GF Score
Get the complete analysis for VVTMF
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VVTMF has been successfully added to your 